Indivi

💡 Eager to know how Indivi, an independent #Techbio company, transforms #smartphones into #precisionmedicine instruments to augment probability of success of #drugdevelopment in #neuroscience? 📅 Book a 30-min meeting with Indivi's CEO Guilhem Dupont next week at JPM Healthcare Conference on Calendly at: https://lnkd.in/eD3jVp53 #makingmeasurablewhatisnotso, #techbio for #biotech, #JPM25, #precisiondrugdevelopment, #defeatneurodegeneration, #parkinson, #alzheimer, #multiplesclerosis.

Indivi wishes #health and #peace have a #headstart in the New Year. Let's meet in 2025 somewhere between being #one and #indivisible. #Individual(s) are the center of all things, where also lies the truth of the border between health and diseases. 📲 Together we'll break down the #sourcecodes of #neurodegeneration at the level of #individual(s). 📲 Computational instruments are ready for prime time albeit craving for more #bilingual #TechBio scientists to join and inflate the blossoming intersection between technology and biology. 🚀 Come and join us in 2025, as 𝙬𝙚 𝙪𝙣𝙡𝙚𝙖𝙧𝙣 𝙬𝙝𝙖𝙩 𝙬𝙚 𝙝𝙖𝙫𝙚 𝙡𝙚𝙖𝙧𝙣𝙚𝙙. Stay tuned here: https://indivi.io/insights In collaboration with the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB). #makingmeasurablewhatisnotso, #techbio for #biotech, #precisiondrugdevelopment, #defeatneurodegeneration, #parkinsondisease, #alzheimerdisease, #multiplesclerosis.

🚀 Watch Indivi's presentation at the recent CNS Summit as we are '𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗙𝘂𝘁𝘂𝗿𝗲-𝗣𝗿𝗼𝗼𝗳 𝗮𝗻𝗱 𝗛𝗮𝗿𝗱𝘄𝗮𝗿𝗲-𝗔𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗘𝗻𝗱𝗽𝗼𝗶𝗻𝘁𝘀 𝗮𝘀 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗧𝗼𝗼𝗹𝘀 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝘆. Our mission is a signal-to-noise optimization equation. It's about being the needle in a haystack. ▶ #Makingmeasurablewhatisnotso ▶ Accelerating and de-risking drug development in hard-to-treat diseases ▶ Changing the lay of the land in slowly progressive #neurodegeneration where detection of a modest treatment effect size is challenging as disease course is heterogeneous and benchmark clinical measures carry prohibitive noise. More information here: https://indivi.io/insights In collaboration with the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB). #makingmeasurablewhatisnotso, #techbio for #biotech, #precisiondrugdevelopment, #defeatneurodegeneration, #parkinsondisease, #alzheimerdisease, #multiplesclerosis, #CNSSummit, #CNSSummit2024.

🚀 Watch Indivi's presentation at the recent CNS Summit as we are '𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗙𝘂𝘁𝘂𝗿𝗲-𝗣𝗿𝗼𝗼𝗳 𝗮𝗻𝗱 𝗛𝗮𝗿𝗱𝘄𝗮𝗿𝗲-𝗔𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗘𝗻𝗱𝗽𝗼𝗶𝗻𝘁𝘀 𝗮𝘀 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗧𝗼𝗼𝗹𝘀 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝘆. Our mission is a signal-to-noise optimization equation. It's about being the needle in a haystack. ▶ #Makingmeasurablewhatisnotso ▶ Accelerating and de-risking drug development in hard-to-treat diseases ▶ Changing the lay of the land in slowly progressive #neurodegeneration where detection of a modest treatment effect size is challenging as disease course is heterogeneous and benchmark clinical measures carry prohibitive noise. More information here: https://indivi.io/insights In collaboration with the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB). #makingmeasurablewhatisnotso, #techbio for #biotech, #precisiondrugdevelopment, #defeatneurodegeneration, #parkinsondisease, #alzheimerdisease, #multiplesclerosis, #CNSSummit, #CNSSummit2024.

'𝙏𝙝𝙚 𝙢𝙮𝙩𝙝 𝙤𝙛 𝙎𝙞𝙨𝙮𝙥𝙝𝙪𝙨 𝙞𝙣 𝙖𝙘𝙩𝙞𝙤𝙣'. Thank you Prof Ludwig Kappos for your relentless commitment to advancing #digitalendpoints as the next-generation of drug development tools in progressive #multiplesclerosis. Your very own contribution in this field augments the probability of emergence of the first genuinely #antiprogressive therapies in #MS. Congratulations for your (second) European Charcot Foundation 'Otto Hommes' Lecture: 𝙏𝙝𝙚 𝙘𝙝𝙖𝙣𝙜𝙞𝙣𝙜 𝙡𝙖𝙣𝙙𝙨𝙘𝙖𝙥𝙚 𝙤𝙛 𝙘𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙩𝙧𝙞𝙖𝙡𝙨 𝙞𝙣 𝙈𝙎, which was a demonstration of Sisyphean Force. Indivi is privileged to partner with you and the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB). #makingmeasurablewhatisnotso, #techbio for #biotech, #precisionneurology, #defeatneurodegeneration, #multiplesclerosis.

⏱ '𝘼𝙙𝙫𝙖𝙣𝙘𝙞𝙣𝙜 𝙥𝙚𝙧𝙨𝙤𝙣𝙖𝙡𝙞𝙯𝙚𝙙 𝙢𝙚𝙙𝙞𝙘𝙞𝙣𝙚: 𝙩𝙝𝙚 𝙧𝙤𝙡𝙚 𝙤𝙛 𝙙𝙞𝙜𝙞𝙩𝙖𝙡 𝙙𝙖𝙩𝙖 𝙖𝙣𝙙 𝙚𝙭𝙥𝙚𝙧𝙞𝙚𝙣𝙩𝙞𝙖𝙡 𝙠𝙣𝙤𝙬𝙡𝙚𝙙𝙜𝙚 𝙞𝙣 𝙣𝙚𝙪𝙧𝙤𝙡𝙤𝙜𝙮'. Indivi is presenting today at the Global PROMS Initiative. Thank you Paola Zaratin, Giancarlo Comi, patrick vermersch, Ludwig Kappos and the European Charcot Foundation for this exciting invitation to your plenary event on the “𝙎𝙘𝙞𝙚𝙣𝙘𝙚 𝙤𝙛 𝙥𝙚𝙤𝙥𝙡𝙚 𝙬𝙞𝙩𝙝 𝙈𝙎 𝙞𝙣𝙥𝙪𝙩” 𝙞𝙣 𝙩𝙝𝙚 𝙚𝙧𝙖 𝙤𝙛 𝙥𝙚𝙧𝙨𝙤𝙣𝙖𝙡𝙞𝙯𝙚𝙙 𝙢𝙚𝙙𝙞𝙘𝙞𝙣𝙚. 👉 Register here to follow online and help shape the future of #MS and neurological care and research: https://lnkd.in/div5faJw Indivi collaborates with the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB). #makingmeasurablewhatisnotso, #techbio for #biotech, #precisionneurology, #defeatneurodegeneration, #multiplesclerosis, #parkinsondisease, #alzheimerdisease.

Thank you Mario Aguilar for the nice chapter of your STAT Health Tech Newsletter, which is 'Scrutinizing digital measures developed by Biogen' following the licensing of Konectomᵀᴹ to Indivi and our recent publication on '𝗦𝗲𝗻𝘀𝗼𝗿-𝗗𝗲𝗿𝗶𝘃𝗲𝗱 𝗠𝗲𝗮𝘀𝘂𝗿𝗲𝘀 𝗼𝗳 𝗠𝗼𝘁𝗼𝗿 𝗮𝗻𝗱 𝗖𝗼𝗴𝗻𝗶𝘁𝗶𝘃𝗲 𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗣𝗲𝗼𝗽𝗹𝗲 𝗪𝗶𝘁𝗵 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗦𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀 𝗨𝘀𝗶𝗻𝗴 𝗨𝗻𝘀𝘂𝗽𝗲𝗿𝘃𝗶𝘀𝗲𝗱 𝗦𝗺𝗮𝗿𝘁𝗽𝗵𝗼𝗻𝗲-𝗕𝗮𝘀𝗲𝗱 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁𝘀' (https://lnkd.in/dXXnTQyU) 📏 You cannot treat what you cannot measure. More on 𝙆𝙤𝙣𝙚𝙘𝙩𝙤𝙢: https://konectom.com More on 𝙄𝙣𝙙𝙞𝙫𝙞: https://indivi.io/insights #makingmeasurablewhatisnotso, #techbio for #biotech, #precisionneurology, #defeatneurodegeneration, #parkinsondisease, #alzheimerdisease, #multiplesclerosis. https://lnkd.in/dgZrYhzx

Tomorrow, Indivi and Emmanuel Bartholomé will pitch at the Innovative Health Initiative (IHI) Brokerage event for IHI’s 2025 calls (Brussels, Nov 12-13) and present our Project Proposal: 𝘿𝙀𝘿𝙄𝘾𝘼𝙏𝙀 - 𝘿𝙮𝙣𝙖𝙢𝙞𝙘 𝙀𝙫𝙖𝙡𝙪𝙖𝙩𝙞𝙤𝙣 𝙖𝙣𝙙 𝘿𝙞𝙜𝙞𝙩𝙖𝙡 𝙄𝙣𝙛𝙚𝙧𝙚𝙣𝙘𝙚 𝙤𝙛 𝘾𝙤𝙜𝙣𝙞𝙩𝙞𝙫𝙚 𝘼𝙜𝙚𝙞𝙣𝙜 𝙩𝙝𝙧𝙤𝙪𝙜𝙝 𝙏𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮 𝙞𝙣 𝙀𝙪𝙧𝙤𝙥𝙚. With Europe’s ageing population, there is an urgent need for accessible, objective, and continuous cognitive health assessments to enhance early detection, disease monitoring and preventive intervention in #Alzheimer's disease (#AD) and related dementias (#ADRD): ▶ 52 𝙢𝙞𝙡𝙡𝙞𝙤𝙣 𝙥𝙚𝙤𝙥𝙡𝙚 𝙖𝙧𝙚 𝙖𝙩 𝙩𝙝𝙚 𝙥𝙧𝙚-𝙨𝙮𝙢𝙥𝙩𝙤𝙢𝙖𝙩𝙞𝙘 𝙨𝙩𝙖𝙜𝙚𝙨 𝙨𝙤𝙢𝙚𝙬𝙝𝙚𝙧𝙚 𝙤𝙣 𝙩𝙝𝙚 #𝘼𝘿 𝙘𝙤𝙣𝙩𝙞𝙣𝙪𝙪𝙢 𝙞𝙣 𝙀𝙪𝙧𝙤𝙥𝙚 (global estimates here:https://lnkd.in/efaQKdjx) ▶ You cannot treat what you cannot measure - Drug development aiming to prevent ADRD requires the capacity to measure cognitive decline in pre-symptomatic individuals. Indivi aims to identify and validate first-in-class #longitudinalbiomarkers of the earliest pre-symptomatic stages of ADRD, through user-adaptive #deepphenotyping digital tools and consumer technologies in an #ecological real-life setting. More to come here: https://lnkd.in/eReHchmy #alzheimerdisease, #makingmeasurablewhatisnotso, #techbio for #biotech, #precisionneurology, #defeatneurodegeneration, #parkinsondisease, #multiplesclerosis.

⚽ It's coming home! Bringing together what belongs together, Indivi will continue to build on #konectom platform legacy in the context of our partnership with Biogen to accelerate and de-risk #drugdevelopment in slowly progressive #neurodegenerative diseases. 💡 Special congratulations to Matthew S. for leading this orchestra of measurement developers with Patrizia Chiesa, Lauren Zajac, Claudia Mazzà, Zhaonan Sun, Gautier Cosne, Adrien Juraver, Emmanuel Bartholomé, Christoph Kanzler, Angelos Karatsidis, Joaquín Peñalver de Andrés, Christine Cong Guo, Gabrielle Simoneau, Johan van Beek, Alf Scotland, Marta Ruiz, Lionel MARTY, Arthur Bonnet, Zeynep Ekin Koca, Benoit Masson, Nolan Campbell, and all co-authors and contributors who took this one to the finish line. This is only #Day2 of #impact for the #BDHdiaspora... 🚀 More on 𝙆𝙤𝙣𝙚𝙘𝙩𝙤𝙢: https://konectom.com More on 𝙄𝙣𝙙𝙞𝙫𝙞: https://indivi.io/insights 📏 You cannot treat what you cannot measure. #makingmeasurablewhatisnotso, #techbio for #biotech, #precisionneurology, #defeatneurodegeneration, #parkinsondisease, #alzheimerdisease, #multiplesclerosis. https://lnkd.in/eS5Jkv3D

🚀 Indivi will present next week at the Boston CNS Summit: '𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗙𝘂𝘁𝘂𝗿𝗲-𝗣𝗿𝗼𝗼𝗳 𝗮𝗻𝗱 𝗛𝗮𝗿𝗱𝘄𝗮𝗿𝗲-𝗔𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗘𝗻𝗱𝗽𝗼𝗶𝗻𝘁𝘀 𝗮𝘀 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗧𝗼𝗼𝗹𝘀 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝘆 - 𝗔 𝗦𝗶𝗴𝗻𝗮𝗹-𝘁𝗼-𝗡𝗼𝗶𝘀𝗲 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗘𝗾𝘂𝗮𝘁𝗶𝗼𝗻' (Monday Nov 11, 2:25-2:40pm). We're getting there, because it's not easy: ▶ To #makemeasurablewhatisnotso ▶ To accelerate and de-risk drug development in neurology ▶ To change the lay of a land of slowly progressive neurodegenerative diseases where detection of a modest treatment effect size is challenging as disease course is heterogeneous, and benchmark clinical measures carry prohibitive noise. More information here: https://indivi.io/insights #makingmeasurablewhatisnotso, #techbio for #biotech, #precisiondrugdevelopment, #defeatneurodegeneration, #parkinsondisease, #alzheimerdisease, #multiplesclerosis, #CNSSummit, #CNSSummit2024.